LUX biotechnology announces appointment of Chief Operating Officer
LUX biotechnology limited (LUX) announced the appointment of Mr Bryan Smith as Chief Operating Officer of the Company.
Bryan Smith joins the management team following over 12 years experience in operations and operational consulting. Mr Smith joins LUX from PricewaterhouseCoopers where his role as Management Consultant, included the delivery of operations and supply chain reviews to verify compliance with appropriate standards (including ISO and FDA) and identify opportunities for cost and service improvement. Mr. Smith previously worked as a LeanSigma Expert for GlaxoSmithKline within their Global Manufacturing and Supply organisation, where he identified and managed step change projects delivering significantly lower operational costs and increased efficiency. Prior to this, Mr. Smith had extensive experience in production management at SmithKline Beecham. On joining LUX, Mr. Smith will manage all operations at LUX and will work to maximise the performance of its processes.
Other news from the department people
